UPDATE: Canaccord Genuity Lowers PT on Gevo on Positive Risk/Reward

In a report published Wednesday, Canaccord Genuity reiterated its Buy rating on Gevo GEVO but lowered its price target from $6.00 to $5.00. Canaccord Genuity noted, “While the Street takes a wait-and-see approach here on the success of this speculative biorefinery business model, we find the technology and ultimate opportunity supporting a positive risk/reward longer term.” Gevo closed on Tuesday at $1.86.